JOHANNESBURG, Feb 8: South Africa has suspended plans to inoculate its front-line health care workers with the Oxford-AstraZeneca vaccine after a small clinical trial suggested that it isn’t effective in preventing mild to moderate illness from the variant dominant in the country.

In the first phase, each of the around 450,000 frontline workers will get two doses of ‘Covishield’ vaccines